Consolidated Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7551556

Concept 2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
Consolidated statement of income
Statement of income
Net sales
14,420,000,000 JPY
1,560,000,000 JPY
16,036,000,000 JPY
16,023,000,000 JPY
55,000,000 JPY
-13,000,000 JPY
44,000,000 JPY
15,269,000,000 JPY
13,646,000,000 JPY
-15,000,000 JPY
1,593,000,000 JPY
15,284,000,000 JPY
Operating expenses
Selling, general and administrative expenses
5,759,000,000 JPY
5,587,000,000 JPY
Operating expenses
Cost of sales
8,559,000,000 JPY
8,017,000,000 JPY
Operating profit (loss)
2,021,000,000 JPY
-1,000,000 JPY
1,993,000,000 JPY
1,704,000,000 JPY
-27,000,000 JPY
-288,000,000 JPY
-18,000,000 JPY
1,664,000,000 JPY
1,728,000,000 JPY
-169,000,000 JPY
124,000,000 JPY
1,833,000,000 JPY
Gross profit (loss)
7,463,000,000 JPY
7,252,000,000 JPY
Ordinary profit (loss)
1,809,000,000 JPY
1,805,000,000 JPY
Net sales
Cost of sales
Non-operating income
197,000,000 JPY
212,000,000 JPY
Dividend income
178,000,000 JPY
177,000,000 JPY
Interest income
0 JPY
0 JPY
Selling, general and administrative expenses
Non-operating income
Other
19,000,000 JPY
34,000,000 JPY
Extraordinary income
64,000,000 JPY
JPY
Non-operating expenses
Interest expenses
11,000,000 JPY
13,000,000 JPY
Other
46,000,000 JPY
44,000,000 JPY
Non-operating expenses
93,000,000 JPY
71,000,000 JPY
Profit (loss) before income taxes
1,873,000,000 JPY
1,805,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
64,000,000 JPY
JPY
Income taxes - current
346,000,000 JPY
199,000,000 JPY
Income taxes - deferred
98,000,000 JPY
283,000,000 JPY
Income taxes
444,000,000 JPY
482,000,000 JPY
Profit (loss)
1,428,000,000 JPY
1,323,000,000 JPY
Profit (loss) attributable to owners of parent
1,428,000,000 JPY
1,323,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,076,000,000 JPY
323,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-7,000,000 JPY
6,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
66,000,000 JPY
139,000,000 JPY
Other comprehensive income
1,135,000,000 JPY
469,000,000 JPY
Profit attributable to
Comprehensive income
2,563,000,000 JPY
1,792,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,563,000,000 JPY
1,792,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.